Basic Materials Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 10/25/2024 | PUT | $26.50 | 608 | +608 | |
| 09/20/2024 | PUT | $20.50 | 60 | +60 | |
| 09/20/2024 | PUT | $20.00 | 30 | +30 | |
| 09/20/2024 | CALL | $26.50 | 31 | +24 | +342.86% |
| 09/20/2024 | CALL | $24.00 | 202 | +14 | +7.45% |
| 09/20/2024 | PUT | $21.00 | 18,646 | +10 | +0.05% |
| 01/15/2027 | PUT | $37.00 | 0 | 0 | |
| 01/15/2027 | PUT | $40.00 | 0 | 0 | |
| 09/27/2024 | CALL | $26.50 | 3 | -1 | -25.00% |
| 10/18/2024 | CALL | $26.00 | 255 | -1 | -0.39% |
| 02/21/2025 | CALL | $25.00 | 421 | -2 | -0.47% |
| 11/15/2024 | CALL | $29.00 | 316 | -5 | -1.56% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Price (T.Rowe) Capital Appreciation Fund | 3.75% | 25.32M | 527.19M |
| Vanguard Total Stock Market Index Fund | 2.89% | 19.47M | 405.38M |
| Price (T.Rowe) Mid Cap Growth Fund | 2.63% | 17.75M | 369.5M |
| Vanguard Mid-Cap Index Fund | 2.21% | 14.93M | 310.81M |
| Vanguard Extended Market Index Fund | 1.36% | 9.2M | 191.49M |
| Parnassus Mid-Cap Fund | 1.30% | 8.75M | 182.22M |
| Price (T.Rowe) Growth Stock Fund Inc. | 1.25% | 8.4M | 174.95M |
| Janus Henderson Enterprise Fund | 1.23% | 8.29M | 172.61M |
| Vanguard/Windsor Fund Inc. | 0.97% | 6.57M | 136.72M |
| JNL Series Trust-JNL/T. Rowe Price Capital Appreciation Fund | 0.90% | 6.04M | 125.8M |
Biopharmaceutical Excipients Focused Market Insights 2024-2029 Featuring Key Vendors - Merck, BASF, Avantor, Evonik Industries, Roquette Freres, Associated British Foods
08/19 04:47 am
GlobeNewswire Inc.
Read moreGlobal Meta-Xylene Market is Expected to Grow at a CAGR of 6.4% over the Forecast Period (2024 – 2034): states TNR, The Niche Research
08/12 08:43 am
GlobeNewswire Inc.
Read moreGlobal Cell Culture Media Market Set to Reach USD 6,699.93 - GlobeNewswire
07/23 08:30 pm
GlobeNewswire Inc.
Read moreLooking At Avantor's Recent Unusual Options Activity - Benzinga
07/19 02:18 pm
Benzinga
Read moreGDP and manufacturing met the expectations, FTSE 100 opened in green - Investing.com UK
07/11 03:26 am
Investing.com
Read moreAvantor (AVTR) Launches Solutions for Gene Therapy Harvest
07/02 12:16 pm
Zacks Investment Research
Read moreThe Analyst Landscape: 5 Takes On Avantor
06/28 12:01 pm
Benzinga
Read moreReasons Why You Should Retain Avantor (AVTR) Stock for Now
05/30 11:30 am
Zacks Investment Research
Read moreAvantor (AVTR) Q1 Earnings Surpass Estimates, Margins Down
04/29 12:33 pm
Zacks Investment Research
Read moreBeyond The Numbers: 10 Analysts Discuss Avantor Stock
04/29 10:01 am
Benzinga
Read moreTech Stocks Rebound As Magnificent 7 Roar On Strong Earnings, Energy Giants Tumble: What's Driving Markets Friday?
04/26 01:45 pm
Benzinga
Read moreAvantor's Conservative Guidance Is Realistic Post Q1 Earnings Performance: Analyst
04/26 10:51 am
Benzinga
Read moreThe Zacks Analyst Blog Highlights Cigna Group, HCA Healthcare, Avantor and Tenet Healthcare
04/26 08:36 am
Zacks Investment Research
Read moreIs a Surprise Coming for Avantor (AVTR) This Earnings Season?
04/25 12:52 pm
Zacks Investment Research
Read moreELV or AVTR: Which Is the Better Value Stock Right Now?
04/25 11:40 am
Zacks Investment Research
Read moreStay Ahead With 4 Healthcare Stocks Poised for Q1 Earnings Beat
04/25 09:35 am
Zacks Investment Research
Read moreAnalysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
04/24 10:01 am
Zacks Investment Research
Read moreElevance (ELV) Q1 Earnings Beat on Rate Hikes, Guidance Raised
04/18 11:18 am
Zacks Investment Research
Read moreBLCO vs. AVTR: Which Stock Is the Better Value Option?
04/08 11:40 am
Zacks Investment Research
Read more9 Analysts Assess Avantor: What You Need To Know
04/04 02:00 pm
Benzinga
Read moreWhy Is Viatris (VTRS) Down 3.5% Since Last Earnings Report?
03/29 11:30 am
Zacks Investment Research
Read moreThree Reasons to Retain Avantor (AVTR) Stock in Your Portfolio
03/26 11:30 am
Zacks Investment Research
Read moreBLCO or AVTR: Which Is the Better Value Stock Right Now?
03/21 11:40 am
Zacks Investment Research
Read morePediatrix Medical Group, Inc. (MD) Up 11% Since Last Earnings Report: Can It Continue?
03/21 11:30 am
Zacks Investment Research
Read moreBLCO or AVTR: Which Is the Better Value Stock Right Now?
03/21 10:41 am
Zacks Investment Research
Read moreTop 7 Biotech Winners Of Novo Nordisk, Eli Lilly's Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs
03/13 12:35 pm
Benzinga
Read moreNew Strong Sell Stocks for February 20th
02/20 08:22 am
Zacks Investment Research
Read moreAvantor (AVTR) Q4 Earnings & Revenues Top Estimates, Margins Down
02/15 12:20 pm
Zacks Investment Research
Read moreWhere Avantor Stands With Analysts
02/15 10:00 am
Benzinga
Read moreCompared to Estimates, Avantor, Inc. (AVTR) Q4 Earnings: A Look at Key Metrics
02/14 10:30 am
Zacks Investment Research
Read moreCurious about Avantor, Inc. (AVTR) Q4 Performance? Explore Wall Street Estimates for Key Metrics
02/09 10:15 am
Zacks Investment Research
Read moreELV vs. AVTR: Which Stock Is the Better Value Option?
02/02 12:40 pm
Zacks Investment Research
Read moreBooz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday
01/26 11:30 am
Benzinga
Read moreEvaluating Avantor: Insights From 10 Financial Analysts
01/26 09:01 am
Benzinga
Read moreBarclays Maintains Overweight Rating for Avantor: Here's What You Need To Know
12/11 01:00 pm
Benzinga
Read moreViatris (VTRS) Up 5.1% Since Last Earnings Report: Can It Continue?
12/07 12:31 pm
Zacks Investment Research
Read moreWhat 6 Analyst Ratings Have To Say About Avantor
12/07 11:00 am
Benzinga
Read moreAvantor's (AVTR) New Offerings to Aid Cell and Gene Therapy Suite
11/15 10:13 am
Zacks Investment Research
Read moreAvantor (AVTR) Q3 Earnings In-Line With Estimates, Revenues Top
10/30 12:24 pm
Zacks Investment Research
Read moreCompared to Estimates, Avantor, Inc. (AVTR) Q3 Earnings: A Look at Key Metrics
10/27 01:30 pm
Zacks Investment Research
Read moreAvantor, Inc. (AVTR) Q3 Earnings Meet Estimates
10/27 07:25 am
Zacks Investment Research
Read moreWhy Coke, others, may be spared, as a $100 billion opportunity in weight loss drugs unfolds says JPMorgan
10/24 07:37 am
MarketWatch
Read moreAnalysts Estimate Avantor, Inc. (AVTR) to Report a Decline in Earnings: What to Look Out for
10/20 10:00 am
Zacks Investment Research
Read moreRevvity's (RVTY) New Launch to Widen Access to Editing Technology
10/02 10:10 am
Zacks Investment Research
Read moreExpert Ratings for Avantor
09/28 11:00 am
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
09/28 11:00 am
Benzinga
Read moreAlignment Healthcare (ALHC) Soars 5.9%: Is Further Upside Left in the Stock?
09/18 08:52 am
Zacks Investment Research
Read moreAvantor's (AVTR) Tie-Up to Address Temperature-Specific Logistics
09/11 12:37 pm
Zacks Investment Research
Read moreNew Strong Sell Stocks for September 11th
09/11 07:40 am
Zacks Investment Research
Read more